ライフサイエンスコーパス: clonogenic

1 tegrin and DLL1 and were highly adhesive and clonogenic.

2 opulations of ALDH(+) cells that were highly clonogenic.

3 romotes cell proliferation and increases the clonogenic ability in breast cancer cells.

4 The clonogenic ability of CaP cells expressing Lin28 was det

5 nal cancer cell lines reduced cell invasion, clonogenic ability, and epithelial-mesenchymal transitio

6 significantly inhibited their proliferation, clonogenic ability, and invasiveness by suppressing extr

7 litaxel-induced senescence, with the loss of clonogenic ability, and the induction of senescence-asso

8 n-1-silenced cells rescued cell motility and clonogenic ability.

9 icity under limiting dilution conditions and clonogenic activity in soft agar.

10 that persistent HGF treatment stimulates the clonogenic activity of ICAM1-positive luminal progenitor

11 used by two mechanisms: (1) decreases in the clonogenic activity of the stem cells and in the endocri

12 Robust clonogenic activity was found to be restricted to a subs

13 ibited enhanced cell proliferation, elevated clonogenic activity, accelerated anchorage-independent g

14 cancer cells, this protein is necessary for clonogenic activity.

15 These MDS HSCs demonstrated dysplastic clonogenic activity.

16 IV p17 protein variants with enhanced B-cell clonogenic activity.

17 urthermore, DCA treatment also abrogated the clonogenic advantage conferred by IDH1 mutation.

18 cally defined as undifferentiated and highly clonogenic ALDH(+)/CD49f(+)/EpCAM(+) luminal progenitors

19 en directly from patients as well as in vivo clonogenic ALL xenograft cells, destroyed the in vivo cl

20 igh nuclear membrane fluctuations are highly clonogenic and also exhibit gene, protein, and functiona

21 apable of propagating tumor growth in both a clonogenic and an orthotopic serial transplantation assa

22 epressed miR, is inhibitory to Ewing Sarcoma clonogenic and anchorage-independent cell growth, even a

23 ing Sarcoma, and that its depletion inhibits clonogenic and anchorage-independent growth in multiple

24 e isolated Kit(low)Cd44(+)Cd34(+) cells were clonogenic and capable of self-renewal and differentiati

25 Clonogenic and differentiation/proliferation assays demo

26 tured human pancreatic tumor cell line using clonogenic and DNA damage assays.

27 eral stem/progenitor cells (SSPCs) possessed clonogenic and high doubling capacities.

28 Consistently, Pten silencing exacerbated the clonogenic and invasive potential of Tp53-deficient bone

29 We found PIP4K2A to be essential for the clonogenic and leukemia-initiating potential of human AM

30 ization by GPx2 is essential for maintaining clonogenic and metastatic capacity, but also for the gen

31 Furthermore, these cells showed clonogenic and multilineage differentiation capacities.

32 Migrating cells were highly clonogenic and multipotent and expressed markers associa

33 fetal c-kit-positive CSCs are self-renewing, clonogenic and multipotent in vitro and in vivo.

34 essing cells in adult sheath tissues possess clonogenic and multipotent properties comparable to thos

35 stics of stem cells: they are self-renewing, clonogenic and multipotent.

36 ALDH(hi) cells also exhibited greater clonogenic and organoid-forming capacity compared with A

37 ghput microscopy, allowing analyses of their clonogenic and proliferative capacity.

38 CDC25A inhibition reduces the clonogenic and proliferative potential of JAK2(V617F)-ex

39 By contrast, the clonogenic and repopulating potential of normal hematopo

40 Our data suggest that CpG may target clonogenic and resistant ALDH(+) cells as well as improv

41 In addition, purified Axin2(lacZ) cells were clonogenic and self-renewing in culture in a Wnt-depende

42 human DF-derived epithelial cells possessed clonogenic and sphere-forming capabilities, as well as e

43 nstrate that Notch3 is expressed in a highly clonogenic and transiently quiescent luminal progenitor

44 Prostate CSCs with enhanced clonogenic and tumor-initiating and metastatic capacitie

45 renewal gene NANOG significantly reduced the clonogenic and tumorigenic capabilities of various cance

46 th the highest Wnt activity exhibited higher clonogenic and tumorigenic potential than pCCSCs with th

47 These cells are self-renewing, clonogenic, and multipotent in vitro.

48 Comet, clonogenic, and WST-1 assays showed that KLF8 expression

49 to CCPM-(177)Lu radiotherapy as measured by clonogenic assay (p<0.05).

50 ulfiram-induced toxicity was investigated by clonogenic assay after treatment of human SK-N-BE(2c) ne

51 mesoderm-derived femur/tibia HSCs, including clonogenic assay and long-term culture.

52 Clonogenic assay experiments are frequently used to dete

53 this, radiation sensitivity, as measured by clonogenic assay of cultured murine (GL261) and human (U

54 The soft agar clonogenic assay showed that T80/KLF8 cells formed signi

55 Moreover, ECs were plated in a single-cell clonogenic assay to evaluate colony-forming ability.

56 n two lung cancer cell lines and performed a clonogenic assay to examine their role in cell prolifera

57 In a clonogenic assay, 19 showed an HCR of 4090 in HT29 cells

58 ns were evaluated on the basis of cell size, clonogenic assay, and expression of putative limbal stem

59 inhibits NHEJ and cell survival assessed by clonogenic assay.

60 The surviving fraction was determined in a clonogenic assay.

61 We evaluated cell survival by a clonogenic assay; apoptosis by Annexin V immunofluoresce

62 In addition, proliferative and clonogenic assays also show that OTUB1 can enhance the p

63 gemcitabine-mediated cell death assessed via clonogenic assays and cleaved caspase 3 expression.

64 Clonogenic assays demonstrated a significant sensitizati

65 Results from clonogenic assays demonstrated hypersensitivity of SelH

66 Clonogenic assays demonstrated that up to 3.6% of Foxl1(

67 Clonogenic assays in HTB9 cells further confirmed that b

68 While clonogenic assays soon fell out of favour due to their h

69 forming unit (BFU-E and CFU-E) colonies, the clonogenic assays that quantify early and late erythroid

70 ive clustering and guide-gene selection, and clonogenic assays to delineate hierarchical genomic and

71 tionship between HER2 and cyclin E, in vitro clonogenic assays were performed to assess combination t

72 ation, decreased colony-forming potential in clonogenic assays, and delayed disease onset in a mouse

73 cing, FACS purification, and robust in vitro clonogenic assays, have changed our view of their roles

74 In clonogenic assays, inhibition of colony formation was ob

75 In clonogenic assays, normal controls show reduced colony f

76 low cytometry, cell-sorting, and single-cell clonogenic assays, we identified Lin(-)CD34(+)CD38(+)CD4

77 Using flow cytometry and clonogenic assays, we showed that inhibiting autophagy w

78 g unit MK cell numbers twofold vs control in clonogenic assays, without substantially modifying MK ma

79 nt CC-RCC in multiple genetic backgrounds by clonogenic assays.

80 cose (glycolytic inhibitor) was evaluated in clonogenic assays.

81 combination therapy was assessed by MTS and clonogenic assays.

82 in HNSCC cells following EphB4 knockdown in clonogenic assays.

83 effectively targeted and eliminated in vivo clonogenic BPL xenograft cells, even at femtomolar-picom

84 geting miR-126 in LSCs and LPs reduced their clonogenic capacity and eliminated leukemic cells, again

85 ate, stem/progenitor cell marker content and clonogenic capacity in the explants but also had the opp

86 cell marker (p63alpha and ABCG2) content and clonogenic capacity in the explants but had opposite eff

87 CCA cells inhibited their proliferation and clonogenic capacity in vitro, and suppressed tumor xenog

88 or medium conditioned by them, increased the clonogenic capacity of colonospheres.

89 nt for MOF acetyltransferase activity in the clonogenic capacity of HSCs and progenitors.

90 differentiated tumor cells and supported the clonogenic capacity of KIT(+) colonosphere cells.

91 lted in chromosomal imbalances and increased clonogenic capacity of liver progenitor cells (LPCs) and

92 role for Bmi-1 in regulating the growth and clonogenic capacity of multiple myeloma cells both in vi

93 y induction of differentiation and decreased clonogenic capacity of myeloid blasts.

94 apamycin (mTOR) with rapamycin increases the clonogenic capacity of primary human oral keratinocytes

95 ot disrupt AML1-ETO's ability to enhance the clonogenic capacity of primary mouse bone marrow cells o

96 se-3 by a compound, NSC321205, increases the clonogenic capacity of primary oral keratinocytes and ca

97 , a noncleavable isoform of HuR promotes the clonogenic capacity of primary oral keratinocytes and de

98 tumor xenografts and this contributed to the clonogenic capacity of the tumor cells.

99 ysplasia proliferated less, showed decreased clonogenic capacity, and formed fewer capillary-like net

100 tendon stem cell marker CD146 and exhibited clonogenic capacity, as well as multilineage differentia

101 alization of radical oxygen species restored clonogenic capacity.

102 leted isoforms in vitro reduces myeloid cell clonogenic capacity.

103 cell (LIC) populations, and suppresses their clonogenic capacity.

104 Thus, PDGFRalpha demarcates the clonogenic cardiogenic Sca1(+) stem/progenitor cell.

105 POR reduced SN30000 reductive metabolism and clonogenic cell death and similarly reduced sensitivity

106 R-dependent radiosensitivity as a measure of clonogenic cell death.

107 3K inhibitor BKM120, as evidenced by reduced clonogenic cell growth and three-dimensional (3D) sphero

108 BMP receptor antagonists also decreased clonogenic cell growth.

109 Clonogenic cell kill after treatment with disulfiram con

110 Clonogenic cell killing and reductive metabolism of PR-1

111 of p16 on radiosensitivity was determined by clonogenic cell survival and tumor growth delay assays.

112 The role of their lognormal distribution in clonogenic cell survival was evaluated.

113 educed TRAIL-induced apoptosis and increased clonogenic cell survival.

114 published high-throughput and high accuracy clonogenic cell-survival data for therapeutic scanned pr

115 ensitivity to radiation-induced postmitotic (clonogenic) cell death.

116 rectly sorted (uncultured) or a single-cell (clonogenic) cell population from primary tissue can diff

117 Destruction of clonogenic cells in the crypt following irradiation are

118 nin alone results in the formation of highly clonogenic cells that are nonmotile and prone to undergo

119 ls represent a highly enriched population of clonogenic cells--notably, the isolated cells exhibited

120 Here, using a clonogenic coculture growth system and a xenograft mouse

121 ore, Casp9b expression blocked inhibition of clonogenic colony formation by erlotinib.

122 e reversion of EMT, the loss of TIC-mediated clonogenic colony formation, and the loss of cell motili

123 consistent with a decrease in the number of clonogenic colony-forming unit-fibroblasts within the BM

124 Clonogenic culture of isolated single Bmi1(+) ISCs yield

125 methods previously employed to fit the same clonogenic data.

126 The main effector mechanism of the clonogenic death induced by mir-145 was that of accelera

127 ipheral T cells, but lacked proliferative or clonogenic effects on lung cancer cells.

128 ucosal damage occurs through decline in stem/clonogenic epithelial cell loss mediated by microvascula

129 re somatic mutations, leading to disease and clonogenic evolution.

130 fied CD44(+) prostate cancer cells inhibited clonogenic expansion, tumor regeneration, and metastasis

131 Hep3B and Huh7) increased tumor cell growth, clonogenic formation, migration and invasion, whereas kn

132 c ALL xenograft cells, destroyed the in vivo clonogenic fraction of ALL blast cells, and, at nontoxic

133 ockdown breast cancer cells, suggesting that clonogenic function is served by either CRD-BP isoform.

134 strate the cloning and propagation of highly clonogenic, 'ground state' stem cells of the human intes

135 ells (LT-HSC) in vitro resulted in dispersed clonogenic growth and expression of genes involved in mi

136 inhibits cellular growth, wound healing and clonogenic growth and induces apoptosis of H295R cells i

137 ent (TME) may similarly influence tumor cell clonogenic growth and self-renewal.

138 ally replaced RhoA with respect to invasion, clonogenic growth and survival.

139 a significant decrease in cell viability and clonogenic growth in a dose-dependent manner.

140 specifically induced cell death and reduced clonogenic growth in BMSC-adherent myeloma cell lines, a

141 mewhat, and a significant 3-fold increase in clonogenic growth in soft agar was also noted.

142 Prox1-GFP(+) cells exhibited sustained clonogenic growth in vitro, and lineage-tracing of Prox1

143 knockdown of beta-catenin also abrogates the clonogenic growth of AE(+) mouse HSPCs and human leukemi

144 ow expression levels, CRD-BP is required for clonogenic growth of breast cancer cells.

145 The clonogenic growth of human colony-forming units was also

146 0), 0.3 muM) and inhibited the viability and clonogenic growth of MDA-MB-231 and MDA-MB-468 cells wit

147 uced pronounced apoptosis in and reduced the clonogenic growth of multiple AML lines and primary AML

148 allopian tube secretory epithelial cells and clonogenic growth of ovarian cancer cells overexpressing

149 icacy of PI3K/mTOR inhibition in suppressing clonogenic growth of ovarian cancer cells with GAB2 over

150 efficacy of the KAT inhibitors in decreasing clonogenic growth of primary AML patient samples.

151 Finally, we show that the clonogenic growth of primary murine MLL-AF9-expressing l

152 estigated its role in promoting invasion and clonogenic growth of uveal melanoma cells.

153 cle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identi

154 Tumor regrowth indicates that clonogenic growth potential is continually maintained, b

155 IIIc suppressed apoptotic activity, enhanced clonogenic growth, and induced disintegration of the blo

156 be a mediator of mutant p53 GOF activity in clonogenic growth, architectural tissue remodeling, migr

157 the impairment of anchorage-independent and clonogenic growth, consistent with an oncogenic function

158 c cell lines and efficiently abrogates their clonogenic growth.

159 equire laminin binding to beta1-integrin for clonogenic growth.

160 cells is both drug resistant and capable of clonogenic growth.

161 (siRNA)-mediated knockdown of proteins, and clonogenic hematopoietic progenitor assays in methylcell

162 otoxicity, without adversely affecting human clonogenic hematopoietic progenitors in vitro, or murine

163 uximab to kill CD138(-)20(+) B cells (highly clonogenic immature cells), and bortezomib to target CD1

164 nificant reduction in the size and number of clonogenic keratinocytes.

165 bolism pathways induces oxidative stress and clonogenic killing in HNSCCs and this strategy may be us

166 8 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemothera

167 rather than DNA damage-mediated endothelial clonogenic lethality, plays a mandatory role in the comp

168 survival and induced differentiation of the clonogenic leukemia-initiating cells.

169 er these progenitors were multipotent at the clonogenic level or there existed heterogeneity within t

170 and host-derived mature hematopoietic cells, clonogenic lineage-committed progenitors and HSCs.

171 epithelial-to-mesenchymal transition to form clonogenic, long-term, self-renewing MSC-like cells.

172 , and demonstrate that this subset of highly clonogenic luminal progenitors is required for mammary g

173 Clonogenic macrophage progenitors of fetal origin were p

174 to CD105(+)CD90(+)CD73(+)CD31(-) multipotent clonogenic mesodermal precursors, which can be isolated

175 associated with changes in the frequency of clonogenic MM cells and the progression-free survival of

176 rs and decreased aggressiveness as judged by clonogenic, motility, and invasion assays.

177 +) and contained large proportions of highly clonogenic multipotential cells.

178 rging strategy targeting mature and immature clonogenic myeloma cell populations in the autograft.

179 These clonogenic neoblasts (cNeoblasts) produce cells that dif

180 e and human, did not adversely impact either clonogenic or multilineage differentiation potential, in

181 -inhibitor-induced multinucleated cells fail clonogenic outgrowth, and high percentages of multinucle

182 helial cells renders these cells amenable to clonogenic outgrowth.

183 herapy, because the preleukemic early thymic clonogenic population needs to be eradicated and its dis

184 ividual cells correlates with differences in clonogenic potential and lineage-specific differentiatio

185 lation within Met-pos neurospheres displayed clonogenic potential and long-term self-renewal ability

186 Of note, Sox2(+) stem cells and clonogenic potential are drastically increased in the mu

187 uced with BCR-ABL1 display slowed growth and clonogenic potential as compared to Fyn wild-type BCR-AB

188 ts or with hepatocyte growth factor restored clonogenic potential in low Wnt activity colon cancer ce

189 The new compounds strongly inhibit the clonogenic potential of acute leukemia cell lines.

190 te to the potent effects of FL118 to inhibit clonogenic potential of colon cancer cells.

191 fter uptake, and maintained the survival and clonogenic potential of HSPCs, presumably by preventing

192 17F) inactivation/downregulation and impairs clonogenic potential of Jak2(V617F) cell lines and PV bu

193 bsence of IL2Rgamma completely abrogated the clonogenic potential of JAK3(A572V), as well as the tran

194 trongly triggered apoptosis and impaired the clonogenic potential of leukemic, but not normal, CD34(+

195 ng potential of human AML cells, and for the clonogenic potential of murine MLL-AF9 AML cells.

196 s well as reduction in the proliferative and clonogenic potential of PCa cells.

197 mportantly, PIP4K2A is also required for the clonogenic potential of primary human AML cells.

198 Plk1 inhibitors decreased proliferation and clonogenic potential of prostate cancer cells.

199 thermore, dinaciclib potently suppressed the clonogenic potential of relapsed NRI AMLs in vitro and p

200 We observed evidence for clonogenic potential of SP cells, as well as the ability

201 he YAP/TAZ co-activators, which maintain the clonogenic potential of these cells.

202 ny assay showed that PLK1 silencing impaired clonogenic potential of TNBC cell lines.

203 H2A ubiquitination activity of PRC1 and for clonogenic potential of U2OS cells.

204 ant, is per se sufficient to confer a B-cell clonogenic potential to the viral protein and modulate,

205 SCF prevented loss of clonogenic potential under differentiation-inducing cond

206 mostly quiescent and associated with higher clonogenic potential when cocultured with BM stromal cel

207 diated DNA damage response, attenuated their clonogenic potential, abrogated camptothecin (CPT)-induc

208 ts in reduced miR-155-induced proliferation, clonogenic potential, and increased apoptosis.

209 including androgen deprivation, exhibit high clonogenic potential, and possess long-term tumor-propag

210 -ErbB receptor inhibitor, diminished growth, clonogenic potential, anoikis resistance and induced apo

211 sufficient to reduce malignant cell growth, clonogenic potential, glucose consumption, lactate secre

212 in these cell lines reduced cell growth and clonogenic potential, whereas inhibition of miR-223 incr

213 cyte/macrophage differentiation and enhances clonogenic potential.

214 cant reduction of RAS-GTP levels and of cell clonogenic potential.

215 pathways in PDAC cell lines inhibited their clonogenic potential.

216 s, and CD45(+)CD34(+) blood progenitors with clonogenic potential.

217 suppresses both normal and CML HSC long-term clonogenic potential.

218 o evaluate the impact of this miRNA on their clonogenic potential.

219 end on CXCR7 for proliferation, survival and clonogenic potential.

220 ular matrix remodeling enzymes, and impaired clonogenic potential.

221 : 1) increased drug resistance; 2) increased clonogenic potential; 3) activation of both Wnt and Hedg

222 rogenitor cells, observing GFP expression in clonogenic progenitor colonies and peripheral blood leuk

223 inhibitor, LY-294002, caused a reduction in clonogenic progenitor number in HPIP-expressing CD34(+)

224 Specification of the clonogenic progenitor of CD8alpha(+) cDCs (the pre-CD8 D

225 ted large numbers of growth factor-dependent clonogenic progeny.

226 ion of miR-28 impairs cell proliferation and clonogenic properties of BL cells by modulating several

227 s validation in comparison with conventional clonogenic radiation survival analysis.

228 reduction in cell number as well as impaired clonogenic radiation survival.

229 gs establish quiescent cells as an effective clonogenic reserve and provide a motivation for investig

230 human neuroblastomas and is required for the clonogenic self-renewal and tumorigenicity of human neur

231 and non-SP cells, where transitions between clonogenic states are modulated by exosome-mediated Wnt

232 liferation rates, and greater induction of a clonogenic, stem-like cell population compared with fema

233 Clonogenic studies indicate that polygamain effectively

234 olonged growth inhibition as well as reduced clonogenic survival (loss of reproductive capacity) but

235 ed apoptotic pathways and markedly increased clonogenic survival after cisplatin treatment.

236 39H1 delays the repair of HC DNA and reduces clonogenic survival after ionizing irradiation.

237 ds to an increase in apoptosis and decreased clonogenic survival and again correlates with APAK expre

238 ting in a decrease in cell proliferation and clonogenic survival and an increase in apoptosis.

239 It also impacted clonogenic survival and anchorage-independent proliferat

240 Cell survival was determined by clonogenic survival and ATP-Glo Viability Assays.

241 ant cells resulted in reduced proliferation, clonogenic survival and delayed G(1)-S transition.

242 MKP1 silencing reduced clonogenic survival and enhanced radiosensitivity in the

243 adiosensitization was evidenced by decreased clonogenic survival and increased DNA double-strand brea

244 Inhibition of NF-kappaB reduced clonogenic survival and induced apoptosis and cytostasis

245 accelerated cellular proliferation, improved clonogenic survival and reduced apoptosis, all of which

246 In addition, TIMP1 played a role in tumor clonogenic survival and vascular density, while TIMP1 in

247 oxyuridine incorporation, Ki-67 staining and clonogenic survival assay.

248 Further, in vitro clonogenic survival assays and in vivo sublethal whole b

249 d AH63 as supra-additive radiosensitisers by clonogenic survival assays and isobologram analyses.

250 Quantification of DNA breaks and clonogenic survival assays confirm a role for TDP1 in re

251 Cell viability and clonogenic survival assays showed that t-DARPP increased

252 ved glioblastoma cell lines, we confirmed by clonogenic survival assays that GSCs were significantly

253 eath and DNA damage (p-H2AX), and to enhance clonogenic survival by cytotoxic chemotherapy.

254 spectively, induced significant decreases in clonogenic survival compared to either drug alone in FaD

255 The combination index for clonogenic survival following radiation and rucaparib tr

256 cess selected for 22Rv1-cells with increased clonogenic survival following subsequent radiation expos

257 tion as seen by decreased cell viability and clonogenic survival in all pancreatic cancer cell lines

258 1 was obligatory for AR-dependent growth and clonogenic survival in both hormone-dependent PC and cas

259 ther than Mcl-1, was associated with loss of clonogenic survival in Granta cells.

260 bining MnPs and AscH- synergized to decrease clonogenic survival in human pancreatic cancer cells.

261 d EIF1AX proteins promoted proliferation and clonogenic survival in LGSC cells, providing the first e

262 PSMA-specific cellular uptake and decreased clonogenic survival in PSMA+ PC3 PIP cells and caused si

263 cient in DAB2IP (shDAB2IP) exhibit increased clonogenic survival in response to ionizing radiation (I

264 s, targeting MUC1-C inhibited the growth and clonogenic survival of both trastuzumab-resistant cells.

265 human mesenchymal stem cells and diminished clonogenic survival of cancer cells.

266 In addition, RIP1 silencing rescued clonogenic survival of cells treated with the combinatio

267 bitor or dominant-negative N17Rac1 abrogates clonogenic survival of HFR-selected breast cancer cells

268 F2 knockdown on proliferation, motility, and clonogenic survival of HIF2-dependent tumor cells in vit

269 RNA specific to its truncated mRNA increased clonogenic survival of ionizing radiation (IR)-exposed c

270 Constitutive hCNT1 expression reduced clonogenic survival of MIA PaCa-2 cells and steeply augm

271 The clonogenic survival of these cells was measured after ex

272 AT3 knockdown on proliferation, motility and clonogenic survival of tumor cells in vitro is phenocopi

273 ls were treated by cisplatin and T2AA, their clonogenic survival was significantly less than that of

274 time, the cellular bioenergetic function and clonogenic survival were largely restored in some cells.

275 ed H2A histone family member X staining) and clonogenic survival were tested in PSMA-positive (PSMA+)

276 Cellular uptake and clonogenic survival were tested in PSMA-positive (PSMA+)

277 exhibited increased DNA damage and decreased clonogenic survival when compared with PSMA- PC3 flu cel

278 oxygen species levels, rate of apoptosis and clonogenic survival, and growth in immune and nonimmune

279 t fibrillarin is required for proliferation, clonogenic survival, and proper ribosomal RNA accumulati

280 nhancing glioblastoma cell proliferation and clonogenic survival, as synemin RNA interference decreas

281 a significant reduction in growth rate, and clonogenic survival, coinciding with the degree of knock

282 lted in radiosensitivity, as seen by reduced clonogenic survival, enhanced apoptotic activity and enh

283 /= 50 nM) significantly decreased viability, clonogenic survival, migration, and invasion of glioblas

284 verified the compounds by in vitro assays of clonogenic survival, proliferation, and migration and in

285 ation with increased, rather than decreased, clonogenic survival.

286 lso reduces cell proliferation, motility and clonogenic survival.

287 f senescence, which contributed to decreased clonogenic survival.

288 damage and senescence, leading to decreased clonogenic survival.

289 creasing apoptotic cell death and decreasing clonogenic survival.

290 results in multipolar anaphases and loss of clonogenic survival.

291 ciated with apoptotic cell death and loss of clonogenic survival.

292 rather, there was a significant reduction of clonogenic survival.

293 ensitivity of cells and their dose-dependent clonogenic survival.

294 ization, apoptosis, replication recovery, or clonogenic survival.

295 inhibition impaired replication recovery and clonogenic survival.

296 RCA1 tumor suppressor, resulting in elevated clonogenic survival.

297 in increased cell growth, proliferation and clonogenic survival.

298 by ABT-737 to promote apoptosis and loss of clonogenic survival.

299 MSCs overexpressing TERT and MYOCD were more clonogenic than mock-transduced MSCs.

300 In a clonogenic tumor cell survival assay, SSRBC surrogate he